Dapagliflozin associates with heart rate variability decline in T2DM patients on GLP-1 receptor agonist therapy: a prospective observational study.

Front Endocrinol (Lausanne) · 2026 · PMC13198993 · PMID 42199788

Europe PMC DOI

hedged sentence

0.0520

closest p · 1.0× alpha

0.0520

boldest claim

The sentences

did not reach statistical significancep=0.052so close (0.05 < p ≤ 0.1)

A similar direction of association was observed for SDANN, although this did not reach statistical significance (estimate 27.939, 95% CI −0.237 to 56.114; p=0.052).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.